Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "Intel"

649 News Found

2022: Predictions for medical and healthcare industry
Opinion | December 20, 2021

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India


ICMR invites EOI for Omicron detection kits
News | December 20, 2021

ICMR invites EOI for Omicron detection kits

The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies


Biogen and TheraPanacea collaborate to advance digital health in neuroscience
Biotech | December 15, 2021

Biogen and TheraPanacea collaborate to advance digital health in neuroscience

Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology


Govt. to organise Innovation Week to encourage startup ecosystem
Startup | December 13, 2021

Govt. to organise Innovation Week to encourage startup ecosystem

The proposed week-long event will comprise specific themes - International engagements, market access and incubation support, funding support to startups etc. and will cover the different areas of the innovation lifecycle


Philips receives FDA 510(k) clearance for acute patient monitors
Digitisation | December 09, 2021

Philips receives FDA 510(k) clearance for acute patient monitors

Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850 pair with advanced software and services to offer clinical decision support, continuous, scalable patient management and enhanced infection control


AWS partners with Pfizer to accelerate drug development
Biotech | December 06, 2021

AWS partners with Pfizer to accelerate drug development

It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies


SPARC to licence Biomodifying’s IP
Biotech | December 05, 2021

SPARC to licence Biomodifying’s IP

SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Biotech | November 26, 2021

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline

Owkin builds best-in-class predictive biomedical AI models and robust data sets